ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Treatment Approaches and Outcomes for Primary Mediastinal Sarcoma: Analysis of 976 Patients

Friday, August 3, 2018

Submitted by

Claire Vernon

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2018.03.068

Author(s)

Kathryn E. Engelhardt, Malcolm M. DeCamp, Anthony D. Yang, Karl Y. Bilimoria, David D. Odell

Engelhardt and colleagues reviewed cases of mediastinal sarcoma in the US National Cancer Database from 2004 to 2012. Overall survival at five years was poor, at only 14.8%, and just under half of patients underwent surgical resection. For patients receiving surgery, an R0 resection was associated with better survival (30.1% versus 18.9%), and surgery combined with radiation therapy was associated with the best survival (40.1%).